Arteaga Duarte, Carlos H.
Peters, Michel L.
de Goeij, Michelle H. M.
Spijkerman, Roy
Postma, Maarten J.
Funding for this research was provided by:
Pfizer
Article History
Received: 5 July 2024
Accepted: 25 January 2025
First Online: 24 February 2025
Declarations
:
: Not Applicable.
: Not Applicable.
: CA is an employee of HEOR ValueHub, which was a paid consultant to Pfizer in connection with the development of this manuscript. MLP, MdG and RS were employees of Pfizer at the time of this study. MJP was a paid consultant to Pfizer in connection with the development of this manuscript and he received grants and honoraria from various pharmaceutical companies, inclusive those developing, producing and marketing COVID-19 vaccines.